Malaria News and Research

Latest Malaria News and Research

Study identifies malaria parasite protein as potential new target for drug treatment to prevent malaria

Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments to prevent malaria being passed to humans.

24 Apr 2013

Rapid Assessment of Malaria device provides faster, more accurate diagnostic test

There, the pitch by company CEO John R. Lewandowski, who opened with the line, "What if I told you I could save one million lives every year with just refrigerator magnets and a laser pointer?", got raves and a replay on Fortune Magazine/CNN online.

24 Apr 2013

AfriCoLeish receives grant from European Union to test new treatments for kala-azar

Research and development (R&D) project, AfriCoLeish, is supported by the European Union Seventh Framework Programme (EU FP7) through a grant of -3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan.

23 Apr 2013

Partnership and accountability among countries will lead to global health successes

In remarks at the Africa Health Forum on Friday in Washington, D.C., Deputy Secretary of State William Burns discussed the evolution of foreign assistance and cooperation "from a donor-recipient relationship to more of a partnership," according to a speech transcript provided by the U.S. State Department.

23 Apr 2013

Global Fund working to fight malaria in Latin America

In the ONE blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes about how the Global Fund to Fight AIDS, Tuberculosis and Malaria is working to prevent malaria in Latin America.

23 Apr 2013

New collaboration to expand vaccine approaches for melanoma

Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.

23 Apr 2013

National Foundation for Infectious Diseases to host 16th Annual Conference on Vaccine Research

The National Foundation for Infectious Diseases will host the 16th Annual Conference on Vaccine Research, April 22-24, 2013, at the Hyatt Regency Inner Harbor in Baltimore, MD.

22 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

Donors must 'seize this opportunity' to fully support the Global Fund

At a recent donor conference in Brussels, Belgium, "the Global Fund to Fight AIDS, Tuberculosis and Malaria presented a compelling case for funding the organization to not only tackle these diseases but also to accelerate gains against them.

22 Apr 2013

Reports examine issues of HIV treatment among prisoners, sex workers, sexual minorities in Zambia

"The recent arrest of Zambian HIV treatment and human rights advocate Paul Kasonkomona for only talking about legal barriers to HIV and other health services for Zambians who are prisoners, sex workers or members of sexual minorities, raises the question of how those barriers can be addressed by the country's board charged with distributing money from the Global Fund to Fight AIDS, Tuberculosis and Malaria" -- the Country Coordinating Mechanism, the Center for Global Health Policy's "Science Speaks" blog writes.

20 Apr 2013

Sustain U.S. global AIDS financing to achieve AIDS-free generation

"The persistent shortchanging of PEPFAR, the President's Emergency Plan for AIDS Relief, is one of the more significant and perplexing trends in America's global health policy," Chris Collins, vice president and director of public policy at amfAR: The Foundation for AIDS Research, writes in the Huffington Post's "The Big Push" blog.

20 Apr 2013

Key points about the Global Fund from Executive Director Dybul

Writing in the International Health Policies blog, Rachel Hammonds of the Institute of Tropical Medicine in Belgium, writes about a "panel discussion organized by several [members of the European Parliament], the Stop Aids Alliance and others at the European Parliament on 8 April" that discussed the Global Fund to Fight AIDS, Tuberculosis and Malaria.

19 Apr 2013

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.

19 Apr 2013

Blog examines implications of synthetic artemisinin production for global health

"This week, PATH and our partners celebrated the official launch of the production line for a new synthetic version of artemisinin, the key ingredient for the gold-standard malaria treatment -- one that plays a major role in protecting the lives of children and adults worldwide," PATH President and CEO Steve Davis writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.

19 Apr 2013

President Obama's budget request signals confidence in Global Fund

President Obama's "budget request demonstrates a strong and well-timed endorsement of the Global Fund [to Fight AIDS, Tuberculosis and Malaria] in advance of the replenishment, and will hopefully leverage similarly strong pledges from other donors," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development, and Jenny Ottenhoff, policy outreach associate at the center, write in the CGD's "Global Health Policy" blog.

18 Apr 2013

New York Times examines indictments of Sierra Leone health officials over misuse of GAVI funding

The New York Times examines the indictment of 29 top health officials "by Sierra Leone's anticorruption agency on charges of misappropriating a half-million dollars in grants from" the GAVI Alliance.

17 Apr 2013

Researchers develop novel microfluidic device to separate, detect non-spherical bioparticles

A bioengineering research team from the National University of Singapore team led by Associate Professor Zhang Yong has developed a novel microfluidic device for efficient, rapid separation and detection of non-spherical bioparticles.

17 Apr 2013

Production of synthetic artemisinin an attack against farmers currently growing the plant

"On Thursday, the founder of Amyris Biotech triumphantly announced production of 70 million doses of the anti-malarial compound artemisinin," Jim Thomas, research program director for ETC group, a technology watchdog that works with farmers' organizations, writes in The Guardian's "Poverty Matters" blog.

16 Apr 2013

Malaria strategies need to target at-risk populations, researchers say

New strategies are needed to fight malaria in countries with low prevalence, because "pockets of infection remain, mainly among men living or working outdoors," according to a paper published in The Lancet, BBC News reports.

16 Apr 2013

Global Fund has achieved impressive results, but more work remains

"This week I had the pleasure to host a preparatory meeting between donors of the Global Fund to Fight AIDS, Tuberculosis and Malaria," European Commissioner for Development Andris Piebalgs writes in the Huffington Post's "The Big Push" blog.

16 Apr 2013

Malaria News and Research

Latest Malaria News and Research

Study identifies malaria parasite protein as potential new target for drug treatment to prevent malaria

Rapid Assessment of Malaria device provides faster, more accurate diagnostic test

AfriCoLeish receives grant from European Union to test new treatments for kala-azar

Partnership and accountability among countries will lead to global health successes

Global Fund working to fight malaria in Latin America

New collaboration to expand vaccine approaches for melanoma

National Foundation for Infectious Diseases to host 16th Annual Conference on Vaccine Research

Edible malarial vaccine may work against other viral and bacterial infections

Donors must 'seize this opportunity' to fully support the Global Fund

Reports examine issues of HIV treatment among prisoners, sex workers, sexual minorities in Zambia

Sustain U.S. global AIDS financing to achieve AIDS-free generation

Key points about the Global Fund from Executive Director Dybul

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Blog examines implications of synthetic artemisinin production for global health

President Obama's budget request signals confidence in Global Fund

New York Times examines indictments of Sierra Leone health officials over misuse of GAVI funding

Researchers develop novel microfluidic device to separate, detect non-spherical bioparticles

Production of synthetic artemisinin an attack against farmers currently growing the plant

Malaria strategies need to target at-risk populations, researchers say

Global Fund has achieved impressive results, but more work remains

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in